Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men
Open Access
- 1 May 2000
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 71 (5) , 1077-1084
- https://doi.org/10.1093/ajcn/71.5.1077
Abstract
Background: Replacing animal protein with soy protein has been shown to reduce total and LDL-cholesterol concentrations in humans. However, the minimum amount of soy protein required for significant reduction of blood lipids is not known. Objective: We evaluated the amount of soy protein needed to reduce blood lipids in moderately hypercholesterolemic men. Design: Eighty-one men with moderate hypercholesterolemia (total cholesterol concentration between 5.70 and 7.70 mmol/L) were studied. After a 3-wk lead-in on a Step I diet, total cholesterol was measured and subjects were randomly divided into 5 groups. For 6 wk, each group received 50 g protein/d, which included isolated soy protein (ISP) and casein, respectively, in the following amounts: 50:0, 40:10, 30:20, 20:30, and 0:50 (control group) g. Blood was collected at baseline and weeks 3 and 6 of the intervention. Results: At week 6, significant reductions (P < 0.05) from baseline compared with the control group were found for non-HDL and total cholesterol and apolipoprotein (apo) B for all ISP groups (except total cholesterol with 40 g ISP). At week 3, significant reductions (P < 0.05) were found in apo B for the groups that consumed ≥30 g ISP and in non-HDL cholesterol for the groups that consumed ≥40 g ISP. HDL-cholesterol, apo A-I, lipoprotein(a), and triacylglycerol concentrations were not significantly affected by dietary treatment. Conclusion: Our findings show that consuming as little as 20 g soy protein/d instead of animal protein for 6 wk reduces concentrations of non-HDL cholesterol and apo B by ≈2.6% and 2.2%, respectively.Keywords
This publication has 18 references indexed in Scilit:
- Lipoprotein[a]: A Predictor of Atherosclerotic DiseaseNutrition Reviews, 2009
- A Randomized Trial Comparing the Effect of Casein With That of Soy Protein Containing Varying Amounts of Isoflavones on Plasma Concentrations of Lipids and LipoproteinsArchives of internal medicine (1960), 1999
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trialsThe Lancet, 1996
- Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoring-mass spectrometryClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Meta-Analysis of the Effects of Soy Protein Intake on Serum LipidsNew England Journal of Medicine, 1995
- Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Multiple regression analysis of differential response to treatment in randomized controlled clinical trialsControlled Clinical Trials, 1991
- Precipitation methods for quantification of lipoproteinsPublished by Elsevier ,1986